Search and Browse
Download
Enter Data
BDBM42928 5-chloranyl-1,3-dihydrobenzimidazole-2-thione::5-chloro-1,3-dihydro-2H-benzimidazole-2-thione::5-chloro-1,3-dihydrobenzimidazole-2-thione::MLS000085362::SMR000020099::cid_2056429
SMILES: Clc1ccc2[nH]c(=S)[nH]c2c1
InChI Key: InChIKey=ZZIHEYOZBRPWMB-UHFFFAOYSA-N
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuclear receptor coactivator 1 (Human) | BDBM42928![]() (5-chloranyl-1,3-dihydrobenzimidazole-2-thione | SM...) | GoogleScholar | UniChem | n/a | n/a | n/a | n/a | >7.94E+4 | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor coactivator 2 (Human) | BDBM42928![]() (5-chloranyl-1,3-dihydrobenzimidazole-2-thione | SM...) | GoogleScholar | UniChem | n/a | n/a | n/a | n/a | >7.94E+4 | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor coactivator 3 (Human) | BDBM42928![]() (5-chloranyl-1,3-dihydrobenzimidazole-2-thione | SM...) | GoogleScholar | UniChem | n/a | n/a | n/a | n/a | >7.94E+4 | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| DNA dC->dU-editing enzyme APOBEC-3G (Human) | BDBM42928![]() (5-chloranyl-1,3-dihydrobenzimidazole-2-thione | SM...) | GoogleScholar | UniChem | n/a | n/a | 5.27E+3 | n/a | n/a | n/a | n/a | n/a | 25 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| DNA dC->dU-editing enzyme APOBEC-3A (Human) | BDBM42928![]() (5-chloranyl-1,3-dihydrobenzimidazole-2-thione | SM...) | GoogleScholar | UniChem | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | 25 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||